2024-01-01 2025-06-30 false No description of principal activity Capium Accounts Production 1.1 05813677 2024-01-01 2025-06-30 05813677 bus:AbridgedAccounts 2024-01-01 2025-06-30 05813677 bus:FRS102 2024-01-01 2025-06-30 05813677 bus:AuditExemptWithAccountantsReport 2024-01-01 2025-06-30 05813677 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2025-06-30 05813677 bus:PrivateLimitedCompanyLtd 2024-01-01 2025-06-30 05813677 2024-01-01 2025-06-30 05813677 2025-06-30 05813677 bus:RegisteredOffice 2024-01-01 2025-06-30 05813677 core:WithinOneYear 2025-06-30 05813677 core:AfterOneYear 2025-06-30 05813677 1 2024-01-01 2025-06-30 05813677 bus:Director1 2024-01-01 2025-06-30 05813677 bus:Director1 2025-06-30 05813677 bus:Director1 2023-01-01 2023-12-31 05813677 2023-01-01 05813677 bus:CompanySecretary1 2024-01-01 2025-06-30 05813677 bus:LeadAgentIfApplicable 2024-01-01 2025-06-30 05813677 2023-01-01 2023-12-31 05813677 2023-12-31 05813677 core:WithinOneYear 2023-12-31 05813677 core:AfterOneYear 2023-12-31 05813677 bus:EntityAccountantsOrAuditors 2023-01-01 2023-12-31 05813677 bus:OrdinaryShareClass1 2024-01-01 2025-06-30 05813677 bus:OrdinaryShareClass1 2025-06-30 05813677 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 05813677 bus:OrdinaryShareClass1 2023-12-31 05813677 core:FurnitureFittings 2024-01-01 2025-06-30 05813677 core:FurnitureFittings 2025-06-30 05813677 core:FurnitureFittings 2023-12-31 05813677 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-06-30 05813677 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-12-31 05813677 core:CostValuation core:Non-currentFinancialInstruments 2025-06-30 05813677 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 05813677 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-06-30 05813677 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-06-30 05813677 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-06-30 05813677 core:Non-currentFinancialInstruments 2025-06-30 05813677 core:Non-currentFinancialInstruments 2023-12-31 05813677 core:ShareCapital 2025-06-30 05813677 core:ShareCapital 2023-12-31 05813677 core:RetainedEarningsAccumulatedLosses 2025-06-30 05813677 core:RetainedEarningsAccumulatedLosses 2023-12-31 05813677 dpl:Item1 2024-01-01 05813677 dpl:Item1 2025-06-30 05813677 dpl:Item1 2023-01-01 05813677 dpl:Item1 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 05813677
England and Wales

 

 

 

SAFEGUARD BIOSYSTEMS LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 January 2024

End date: 30 June 2025
In order to assist you to fulfil your duties under Companies Act 2006, we have prepared for your approval the accounts of Safeguard Biosystems Limited for the period ended 30 June 2025 which comprise the Statement of Comprehensive Income, the Statement of Financial Position, the Statement of Changes in Equity, the Statement of Cash Flows and related notes from the company's accounting records and from information and explanations you have given us.

As a practising member of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://rulebook.accaglobal.com.

This report is made solely to the member of Safeguard Biosystems Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Safeguard Biosystems Limited and state those matters that we have agreed to state to the Board of Safeguard Biosystems Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants and as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Safeguard Biosystems Limited and its members as a body for our work or for this report.

It is your duty to ensure that Safeguard Biosystems Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and Profit of Safeguard Biosystems Limited. You consider that Safeguard Biosystems Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Safeguard Biosystems Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.



....................................................
Allazo Ltd
2 Claridge Court
Lower Kings Road
Berkhamsted
HP4 2AF
22 July 2025
1
 
 
Notes
 
2025
£
  2023
£
Current assets      
Debtors   113 
Cash at bank and in hand 117    92 
117    205 
Creditors: amount falling due within one year   (1,381,018)
Net current assets 117    (1,380,813)
 
Total assets less current liabilities 117    (1,380,813)
Net assets 117    (1,380,813)
 

Capital and reserves
     
Called up share capital 4 1    1 
Profit and loss account 116    (1,380,814)
Shareholders' funds 117    (1,380,813)
 


For the period ended 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

Ultimate Controlling Party
The company's immediate and ultimate parent undertaking is Safeguard DX Limited incorporated in England (company number: 15945484).
The financial statements were approved by the director on 22 July 2025 and were signed by:


-------------------------------
Howard Sherman
Director
2
General Information
Safeguard Biosystems Limited is a private company, limited by shares, registered in England and Wales, registration number 05813677, registration address Quadrant House, Floor 6, 4 Thomas More Square, London, E1W 1YW.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the income statement.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Fittings 33% Straight Line
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
2.

Average number of employees

Average number of employees during the period was 0 (2023 : 0).
3.

Tangible fixed assets

Cost or valuation Fixtures and Fittings   Total
  £   £
At 01 January 2024 1,264    1,264 
Additions  
Disposals (1,264)   (1,264)
At 30 June 2025  
Depreciation
At 01 January 2024 1,264    1,264 
Charge for period  
On disposals (1,264)   (1,264)
At 30 June 2025  
Net book values
Closing balance as at 30 June 2025  
Opening balance as at 01 January 2024  


4.

Share Capital

Allotted, called up and fully paid
2025
£
  2023
£
1 Ordinary share of £1.00 each  
 

3